William Mitchell

 William M. Mitchell, M.D., Ph.D. was appointed the Chairman of the Board of Hemispherx Biopharma, the maker of Ampligenin February 2016 after serving as a Director since July 1998. Dr. Mitchell is a Professor of Pathology, Microbiology & Immunology at Vanderbilt University School of Medicine and is a board certified physician.